AI Will Transform the World, but Legendary Investor Warns Its Arms Race Has a Familiar Trap
Is AI-driven market exuberance irrational? Oaktree's Howard Marks weighs in on valuations, bubbles, and risk.
Stocks · News reference
IBM, Lockheed Martin Establish Quantum Hub Via Armasuisse Offset Agreement, Deploying Quantum Computer By End Of 2026
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Business Rules Management System Market to Reach $4.20 Billion by 2035 as AI-Driven Decision Automation Accelerates | Research by SNS Insider
The global Business Rules Management System (BRMS) market is projected to grow from $1.79 billion in 2025 to $4.20 billion by 2035, with a CAGR of 9.52%. Growth is driven by increasing demand for real-time decision-making, regulatory compliance, enterprise automation, and AI/ML integration. North America leads with 37% market share, while Asia Pacific is the fastest-growing region. Large enterprises dominate with 68% market share, and BFSI is the leading end-use sector at 27%.
AI in Pharmaceutical Market to Hit USD 48.43 Billion by 2035, Growing at 31.76% CAGR – SNS Insider
The global AI in pharmaceutical market is projected to grow from USD 3.07 billion in 2025 to USD 48.43 billion by 2035, with a CAGR of 31.76%. The U.S. market is expected to reach USD 15.10 billion and Europe USD 12.60 billion by 2035. Growth is driven by generative AI, adaptive trials reducing patient enrollment by 40%, regulatory endorsement including FDA's qualification of AIM-NASH, and increased venture capital investment in AI-first drug discovery platforms.
Why Lockheed Martin Stock Popped Today
UBS upgraded Lockheed Martin to buy, citing strong growth prospects from its F-35 fighter jet franchise and missile sales. With a book-to-bill ratio of 3.2x, UBS forecasts 9% annual sales growth and double-digit earnings growth over the next 2-3 years. At 19.2x earnings and less than 14x free cash flow with a 2.6% dividend yield, analysts see Lockheed as an attractive defense stock with earnings growth expected to exceed 19% over five years.
UBS Upgrades Lockheed Martin to Buy, Raises Price Target to $674
Lockheed Martin shares are trading higher after reports suggesting that the EU will purchase more Patriot missiles to transfer to Ukraine for that country to protect its airspace from an expected increase in Russian attacks during the winter months.